Table of Content
1 Immuno-oncology Diagnosis Market Introduction and Overview
1.1 Immuno-oncology Diagnosis Introduction
1.2 Research Purposes
1.3 Report Timeline
1.4 Market Size Analysis by Types
1.5 Market Size Analysis by Applications
1.6 Market Size Analysis by Regions
2 Global Market Growth Trends Analysis
2.1 Global Immuno-oncology Diagnosis Market Size & Forecast (2017-2028)
2.2 Immuno-oncology Diagnosis Growth Trends Analysis by Regions
2.2.1 Immuno-oncology Diagnosis Market Size by Regions: 2017 VS 2021 VS 2027
2.2.2 Immuno-oncology Diagnosis Historic Market Share by Regions (2017-2022)
2.2.3 Immuno-oncology Diagnosis Forecasted Market Size by Regions (2023-2028)
3 Global Immuno-oncology Diagnosis Historical and Forecast Market Analysis by Type
3.1 Global Immuno-oncology Diagnosis Revenue and Market Share by Type
3.2 Global Immuno-oncology Diagnosis Market Forecast by Type (2023-2028)
4 Global Immuno-oncology Diagnosis Historical and Forecast Market Analysis by Applications
4.1 Global Immuno-oncology Diagnosis Revenue Market Share by Application (2017-2022)
4.2 Immuno-oncology Diagnosis Market Forecast by Application (2023-2028)
5 North America Immuno-oncology Diagnosis Market analysis
5.1 North America Immuno-oncology Diagnosis Revenue by Type (2017-2028)
5.2 North America Immuno-oncology Diagnosis Revenue by Application (2017-2028)
5.3 North America Immuno-oncology Diagnosis Revenue and Market Share by Countries
5.3.1 North America Immuno-oncology Diagnosis Revenue by Country (2017-2028)
5.3.2 United States Immuno-oncology Diagnosis Revenue and Growth (2017-2028)
5.3.3 Canada Immuno-oncology Diagnosis Revenue and Growth (2017-2028)
5.3.5 Mexico Immuno-oncology Diagnosis Revenue and Growth (2017-2028)
6 Europe Immuno-oncology Diagnosis Market analysis
6.1 Europe Immuno-oncology Diagnosis Revenue by Type (2017-2028)
6.2 Europe Immuno-oncology Diagnosis Revenue by Application (2017-2028)
6.3 Europe Immuno-oncology Diagnosis Revenue and Market Share by Countries
6.3.1 Europe Immuno-oncology Diagnosis Revenue by Country (2017-2028)
6.3.2 Germany Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
6.3.3 France Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
6.3.4 United Kingdom Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
6.3.5 Russia Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
6.3.6 Italy Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7 Asia-Pacific Immuno-oncology Diagnosis Market analysis
7.1 Asia-Pacific Immuno-oncology Diagnosis Revenue by Type (2017-2028)
7.2 Asia-Pacific Immuno-oncology Diagnosis Revenue by Application (2017-2028)
7.3 Asia-Pacific Immuno-oncology Diagnosis Revenue and Market Share by Countries
7.3.1 Asia-Pacific Immuno-oncology Diagnosis Revenue by Country (2017-2028)
7.3.2 China Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7.3.3 Japan Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7.3.4 South Korea Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7.3.5 India Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7.3.6 Southeast Asia Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
7.3.7 Australia Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
8 Latin America Immuno-oncology Diagnosis Market analysis
8.1 Latin America Immuno-oncology Diagnosis Revenue by Type (2017-2028)
8.2 Latin America Immuno-oncology Diagnosis Revenue by Application (2017-2028)
8.3 Latin America Immuno-oncology Diagnosis Revenue and Market Share by Countries
8.3.1 Latin America Immuno-oncology Diagnosis Revenue by Country (2017-2028)
8.3.2 Brazil Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
8.3.3 Argentina Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
9 Middle East & Africa Immuno-oncology Diagnosis Market analysis
9.1 Middle East & Africa Immuno-oncology Diagnosis Revenue by Type (2017-2028)
9.2 Middle East & Africa Immuno-oncology Diagnosis Revenue by Application (2017-2028)
9.3 Middle East & Africa Immuno-oncology Diagnosis Revenue and Market Share by Countries
9.3.1 Middle East & Africa Immuno-oncology Diagnosis Revenue by Country (2017-2028)
9.3.2 Turkey Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
9.3.3 Saudi Arabia Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
9.3.4 UAE Immuno-oncology Diagnosis Market Size and Forecast (2017-2028)
10 Immuno-oncology Diagnosis Industry Dynamic Analysis
10.1 Immuno-oncology Diagnosis Market Trends Analysis
10.2 Immuno-oncology Diagnosis Market Drivers Analysis
10.3 Immuno-oncology Diagnosis Market Challenges Analysis
10.4 Immuno-oncology Diagnosis Market Restraints Analysis
10.5 Immuno-oncology Diagnosis Industry Mergers & Acquisitions
10.6 Immuno-oncology Diagnosis Industry New Entrants and Expansion Plans
11 Key Players Analysis
11.1 Global Immuno-oncology Diagnosis Revenue and Market Share Analysis by Key Players
11.2 Global Immuno-oncology Diagnosis Market Concentration Rate Analysis
11.2.1 Top 3 Immuno-oncology Diagnosis Key Players Market Share
11.2.2 Top 6 Immuno-oncology Diagnosis Key Players Market Share

11.3 10x Genomics
11.3.1 Business Overview
11.3.2 Immuno-oncology Diagnosis Major Business
11.3.3 10x Genomics Product and Service Introduction
11.3.4 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.3.5 Recent Developments and Future Plans
11.4 Abbott Laboratories
11.4.1 Business Overview
11.4.2 Immuno-oncology Diagnosis Major Business
11.4.3 Abbott Laboratories Product and Service Introduction
11.4.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.4.5 Recent Developments and Future Plans
11.5 Abcam
11.5.1 Business Overview
11.5.2 Immuno-oncology Diagnosis Major Business
11.5.3 Abcam Product and Service Introduction
11.5.4 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.5.5 Recent Developments and Future Plans
11.6 Adaptive Biotechnologies
11.6.1 Business Overview
11.6.2 Immuno-oncology Diagnosis Major Business
11.6.3 Adaptive Biotechnologies Product and Service Introduction
11.6.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.6.5 Recent Developments and Future Plans
11.7 Aethlon Medical
11.7.1 Business Overview
11.7.2 Immuno-oncology Diagnosis Major Business
11.7.3 Aethlon Medical Product and Service Introduction
11.7.4 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.7.5 Recent Developments and Future Plans
11.8 Agena Bioscience
11.8.1 Business Overview
11.8.2 Immuno-oncology Diagnosis Major Business
11.8.3 Agena Bioscience Product and Service Introduction
11.8.4 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.8.5 Recent Developments and Future Plans
11.9 Angle plc
11.9.1 Business Overview
11.9.2 Immuno-oncology Diagnosis Major Business
11.9.3 Angle plc Product and Service Introduction
11.9.4 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.9.5 Recent Developments and Future Plans
11.10 Apocell
11.10.1 Business Overview
11.10.2 Immuno-oncology Diagnosis Major Business
11.10.3 Apocell Product and Service Introduction
11.10.4 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.10.5 Recent Developments and Future Plans
11.11 ARUP Laboratories
11.11.1 Business Overview
11.11.2 Immuno-oncology Diagnosis Major Business
11.11.3 ARUP Laboratories Product and Service Introduction
11.11.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.11.5 Recent Developments and Future Plans
11.12 Beckman Coulter
11.12.1 Business Overview
11.12.2 Immuno-oncology Diagnosis Major Business
11.12.3 Beckman Coulter Product and Service Introduction
11.12.4 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.12.5 Recent Developments and Future Plans
11.13 Becton Dickinson
11.13.1 Business Overview
11.13.2 Immuno-oncology Diagnosis Major Business
11.13.3 Becton Dickinson Product and Service Introduction
11.13.4 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.13.5 Recent Developments and Future Plans
11.14 Bioarray Genetics
11.14.1 Business Overview
11.14.2 Immuno-oncology Diagnosis Major Business
11.14.3 Bioarray Genetics Product and Service Introduction
11.14.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.14.5 Recent Developments and Future Plans
11.15 BioCartis
11.15.1 Business Overview
11.15.2 Immuno-oncology Diagnosis Major Business
11.15.3 BioCartis Product and Service Introduction
11.15.4 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.15.5 Recent Developments and Future Plans
11.16 Biocept
11.16.1 Business Overview
11.16.2 Immuno-oncology Diagnosis Major Business
11.16.3 Biocept Product and Service Introduction
11.16.4 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.16.5 Recent Developments and Future Plans
11.17 Biodesix Inc
11.17.1 Business Overview
11.17.2 Immuno-oncology Diagnosis Major Business
11.17.3 Biodesix Inc Product and Service Introduction
11.17.4 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.17.5 Recent Developments and Future Plans
11.18 BioFluidica
11.18.1 Business Overview
11.18.2 Immuno-oncology Diagnosis Major Business
11.18.3 BioFluidica Product and Service Introduction
11.18.4 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.18.5 Recent Developments and Future Plans
11.19 BioGenex 40 bioMrieux
11.19.1 Business Overview
11.19.2 Immuno-oncology Diagnosis Major Business
11.19.3 BioGenex 40 bioMrieux Product and Service Introduction
11.19.4 BioGenex 40 bioMrieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.19.5 Recent Developments and Future Plans
11.20 Bio-Rad
11.20.1 Business Overview
11.20.2 Immuno-oncology Diagnosis Major Business
11.20.3 Bio-Rad Product and Service Introduction
11.20.4 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.20.5 Recent Developments and Future Plans
11.21 Bio-Techne
11.21.1 Business Overview
11.21.2 Immuno-oncology Diagnosis Major Business
11.21.3 Bio-Techne Product and Service Introduction
11.21.4 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.21.5 Recent Developments and Future Plans
11.22 Bristol-Myers Squibb
11.22.1 Business Overview
11.22.2 Immuno-oncology Diagnosis Major Business
11.22.3 Bristol-Myers Squibb Product and Service Introduction
11.22.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.22.5 Recent Developments and Future Plans
11.23 Cancer Genetics
11.23.1 Business Overview
11.23.2 Immuno-oncology Diagnosis Major Business
11.23.3 Cancer Genetics Product and Service Introduction
11.23.4 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.23.5 Recent Developments and Future Plans
11.24 Caris Molecular Diagnostics
11.24.1 Business Overview
11.24.2 Immuno-oncology Diagnosis Major Business
11.24.3 Caris Molecular Diagnostics Product and Service Introduction
11.24.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.24.5 Recent Developments and Future Plans
11.25 CellMax Life
11.25.1 Business Overview
11.25.2 Immuno-oncology Diagnosis Major Business
11.25.3 CellMax Life Product and Service Introduction
11.25.4 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.25.5 Recent Developments and Future Plans
11.26 Charles River Laboratories
11.26.1 Business Overview
11.26.2 Immuno-oncology Diagnosis Major Business
11.26.3 Charles River Laboratories Product and Service Introduction
11.26.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.26.5 Recent Developments and Future Plans
11.27 Chronix Biomedical
11.27.1 Business Overview
11.27.2 Immuno-oncology Diagnosis Major Business
11.27.3 Chronix Biomedical Product and Service Introduction
11.27.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.27.5 Recent Developments and Future Plans
11.28 Circulogene
11.28.1 Business Overview
11.28.2 Immuno-oncology Diagnosis Major Business
11.28.3 Circulogene Product and Service Introduction
11.28.4 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.28.5 Recent Developments and Future Plans
11.29 Clearbridge BioMedics
11.29.1 Business Overview
11.29.2 Immuno-oncology Diagnosis Major Business
11.29.3 Clearbridge BioMedics Product and Service Introduction
11.29.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.29.5 Recent Developments and Future Plans
11.30 Clinical Genomics
11.30.1 Business Overview
11.30.2 Immuno-oncology Diagnosis Major Business
11.30.3 Clinical Genomics Product and Service Introduction
11.30.4 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.30.5 Recent Developments and Future Plans
11.31 Pfizer
11.31.1 Business Overview
11.31.2 Immuno-oncology Diagnosis Major Business
11.31.3 Pfizer Product and Service Introduction
11.31.4 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.31.5 Recent Developments and Future Plans
11.32 Promega
11.32.1 Business Overview
11.32.2 Immuno-oncology Diagnosis Major Business
11.32.3 Promega Product and Service Introduction
11.32.4 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.32.5 Recent Developments and Future Plans
11.33 Protagen Diagnostics
11.33.1 Business Overview
11.33.2 Immuno-oncology Diagnosis Major Business
11.33.3 Protagen Diagnostics Product and Service Introduction
11.33.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.33.5 Recent Developments and Future Plans
11.34 Qiagen
11.34.1 Business Overview
11.34.2 Immuno-oncology Diagnosis Major Business
11.34.3 Qiagen Product and Service Introduction
11.34.4 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.34.5 Recent Developments and Future Plans
11.35 Quanterix
11.35.1 Business Overview
11.35.2 Immuno-oncology Diagnosis Major Business
11.35.3 Quanterix Product and Service Introduction
11.35.4 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.35.5 Recent Developments and Future Plans
11.36 Rarecells SAS
11.36.1 Business Overview
11.36.2 Immuno-oncology Diagnosis Major Business
11.36.3 Rarecells SAS Product and Service Introduction
11.36.4 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.36.5 Recent Developments and Future Plans
11.37 Roche Diagnostics
11.37.1 Business Overview
11.37.2 Immuno-oncology Diagnosis Major Business
11.37.3 Roche Diagnostics Product and Service Introduction
11.37.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.37.5 Recent Developments and Future Plans
11.38 Siemens
11.38.1 Business Overview
11.38.2 Immuno-oncology Diagnosis Major Business
11.38.3 Siemens Product and Service Introduction
11.38.4 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share
11.38.5 Recent Developments and Future Plans
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.2.3 Legal Disclaimer